Chutes & Ladders—Former FDA deputy joins AI biotech's board
About three months after leaving her post as the FDA’s principal deputy commissioner, Namandjé Bumpus, Ph.D., has found a new venture as a member of Recursion’s board of directors.
About three months after leaving her post as the FDA’s principal deputy commissioner, Namandjé Bumpus, Ph.D., has found a new venture as a member of Recursion’s board of directors.
